FDA Fast Track’s Prevail’s PROO1 for Parkinson’s; shares up 12% premarket – Seeking Alpha

FDA Fast Track’s Prevail’s PROO1 for Parkinson’s; shares up 12% premarket – Seeking Alpha
FDA Fast Track's Prevail's PROO1 for Parkinson's; shares up 12% premarket  Seeking AlphaPrevail Therapeutics (PRVL) is up 12% premarket on light volume on the heels of the FDA designating gene therapy PR001 for Fast Track review for the treatm. ... read more
Source: Google NewsPublished on 2019-07-08